Neil Stahl - EVP Research and Development at Regeneron Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP Research and Development
Stock Symbol
REGN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Neil Stahl - trading volume in the past year for Regeneron Pharmaceuticals, Inc.

Holdings reported by Neil Stahl for Regeneron Pharmaceuticals, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 50,999 $49.9 M $979.25 Feb 26, 2024 Direct
Common Stock 5,834 $5.71 M $979.25 Feb 26, 2024 By 401(k) Plan
Common Stock 4,605 $4.51 M $979.25 Feb 26, 2024 by Spouse as Trustee
Non-Qualified Stock Option (right to buy) 0 Feb 2, 2024 Direct Common Stock

Transactions reported by Neil Stahl for Regeneron Pharmaceuticals, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership